Doxazosin Tablet
Product Images NDC 71610-043

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71610-043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 4mg (71610 0043 60)

Doxazosin is a medication that comes in 4mg strength and is available in a bottle of 90 tablets, which can be used to treat hypertension, urinary retention, and other related medical conditions. The text also includes the product code "X eGSR" which may indicate a specific batch or manufacturing information, but more context is needed to determine this.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Doxazosin-structure (Doxazosin Structure)

FDA Label Image

Figure-1-study1 (Figure 1 Study1)

FDA Label Image

Table-1 (Table 1)

This is a summary of effectiveness data for Placero-controlled trials in FABLE 1. The table includes mean baseline and mean change endpoint values for maximum flow rate, as well as data related to dosage levels and placebo responses in multiple studies. Two of the studies used questionnaires to assess efficacy. The change in endpoint is defined as the dosage level during the efficacy phase. The study was conducted with 36 patients who received a dose of 4mg doxazosin. There were significant improvements in mean change compared to placebo in some studies.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.